Cured colorectal cancer patients: "All patients went into remission, without serious side effects"

Cured colorectal cancer patients: “All patients went into remission, without serious side effects”

The use of the antibody dostarlimab has allowed 18 patients with colorectal cancer to achieve a cure, according to a study published this Sunday in the United States. Jean-Baptiste Bachet, an oncologist from Pitié-Salpêtrière, deciphers the advances that this therapy can offer. A revolutionary clinical trial? Posted on Sunday in new England Journal Of Medicine, …

Cured colorectal cancer patients: “All patients went into remission, without serious side effects” Read More »